Plasticity in neuroblastoma cell identity defines a noradrenergic-to-mesenchymal transition (Nmt)

37Citations
Citations of this article
96Readers
Mendeley users who have this article in their library.

Abstract

Neuroblastoma, a pediatric cancer of the peripheral sympathetic nervous system, is characterized by an important clinical heterogeneity, and high-risk tumors are associated with a poor overall survival. Neuroblastoma cells may present with diverse morphological and biochemical properties in vitro, and seminal observations suggested that interconversion between two phenotypes called N-type and S-type may occur. In 2017, two main studies provided novel insights into these subtypes through the characterization of the transcriptomic and epigenetic landscapes of a panel of neuroblastoma cell lines. In this review, we focus on the available data that define neuroblastoma cell identity and propose to use the term noradrenergic (NOR) and mesenchymal (MES) to refer to these identities. We also address the question of transdifferentiation between both states and suggest that the plasticity between the NOR identity and the MES identity defines a noradrenergicto-mesenchymal transition, reminiscent of but different from the well-established epithelial-tomesenchymal transition.

Cite

CITATION STYLE

APA

Gautier, M., Thirant, C., Delattre, O., & Janoueix-Lerosey, I. (2021, June 2). Plasticity in neuroblastoma cell identity defines a noradrenergic-to-mesenchymal transition (Nmt). Cancers. MDPI AG. https://doi.org/10.3390/cancers13122904

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free